1. Home
  2. BNR vs RPID Comparison

BNR vs RPID Comparison

Compare BNR & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.35

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$2.16

Market Cap

204.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
RPID
Founded
2014
2006
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.7M
204.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BNR
RPID
Price
$16.35
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
29.5K
279.2K
Earning Date
03-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
$111.65
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$2.18
$1.91
52 Week High
$41.72
$4.94

Technical Indicators

Market Signals
Indicator
BNR
RPID
Relative Strength Index (RSI) 35.45 31.32
Support Level $15.61 $2.01
Resistance Level $23.42 $4.48
Average True Range (ATR) 1.24 0.22
MACD 0.07 0.00
Stochastic Oscillator 4.17 17.02

Price Performance

Historical Comparison
BNR
RPID

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: